WPG Advisers’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.51K Hold
89
0.01% 821
2026
Q1
$8.57K Hold
89
0.01% 727
2025
Q4
$8.66K Hold
89
0.01% 749
2025
Q3
$6.33K Hold
89
﹤0.01% 831
2025
Q2
$5.32K Buy
89
+36
+68% +$1.97K ﹤0.01% 857
2025
Q1
$2.78K Buy
53
+43
+430% +$2.42K ﹤0.01% 1042
2024
Q4
$550 Buy
+10
New +$526 ﹤0.01% 1327

Other funds holding IRMD

WPG Advisers's IRMD Position: Q2 2026 in Review

WPG Advisers held its iRadimed (IRMD) position steady in Q2 2026 at 89 shares worth $8.51K. The position accounts for 0.01% of the portfolio, ranked #821.

WPG Advisers first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.66K in Q4 2025. 82 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • WPG Advisers held 89 shares of iRadimed worth $8.51K as of Q2 2026.
  • WPG Advisers left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #821 holding.
  • WPG Advisers first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's iRadimed position peaked at $8.66K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.